GENE ONLINE|News &
Financial Times’ US Pharma Biotech Summit 2022: Track & Invest in American Life Sciences
healthcare and driving forces of the biotech industry of the future and its shaping of public health infrastructure.
In a discussion panel titled “Navigating the American life sciences investment landscape”, thought leaders in healthcare investment shared their views on how the biotech market is fast growing and the challenges in raising capital from different avenues. Moderated by Sujeet Indap, US Lex Editor, Financial Times, the panelists included:
- David Lee, CEO, Servier Pharmaceuticals
- Karen Snow, Senior VP, Head of US Listings and Revenue, Nasdaq
- Steven Zachary, Managing Partner, Sands Capital
It's free! Log in now to read
LATEST
